Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Non-Current Deferred Tax Liability (2023 - 2025)

Xtant Medical Holdings (XTNT) reported Non-Current Deferred Tax Liability of $5000.0 for Q4 2025, down 88.1% year-over-year from $42000.0 in Q4 2024, and down 88.1% on a QoQ basis from $42000.0 in Q4 2024.

Xtant Medical Holdings (XTNT) has 3 years of Non-Current Deferred Tax Liability data on file, last reported at $5000.0 in Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability fell 88.1% year-over-year to $5000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5000.0 (down 88.1% YoY) and the FY2025 annual result came in at $5000.0, down 88.1% from the prior year.
  • Non-Current Deferred Tax Liability retreated to $5000.0 in Q4 2025 per XTNT's latest filing, from $42000.0 in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $42000.0 in Q4 2024 and bottomed at $5000.0 in Q4 2025.
  • The 3-year median for Non-Current Deferred Tax Liability is $21000.0 (2023), against an average of $22666.7.
  • The widest annual swing landed in 2024, when Non-Current Deferred Tax Liability surged 100.0%; it then sank 88.1% in 2025.
  • Tracing XTNT's Non-Current Deferred Tax Liability over 3 years: stood at $21000.0 in 2023, then surged by 100.0% to $42000.0 in 2024, then slumped by 88.1% to $5000.0 in 2025.
  • Per Business Quant, the three latest XTNT Non-Current Deferred Tax Liability figures stand at $5000.0 (Q4 2025), $42000.0 (Q4 2024), and $21000.0 (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Xtant Medical Holdings 64.46 Mn 47.14 Mn 17.75 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 5,000.00
Dec 31, 2025 5,000.00
Dec 31, 2024 42,000.00
Dec 31, 2024 42,000.00
Dec 31, 2023 21,000.00
Dec 31, 2023 21,000.00